Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/31/2025

Investigation Guidelines for Erythromelalgia

Hematologic Screening

Neurophysiological Testing

Genetic Testing

Critical Pitfalls

Erythromelalgia Diagnosis and Evaluation

Clinical Evaluation

  • The American College of Physicians recommends that the diagnosis of erythromelalgia be based primarily on clinical history and physical examination during a symptomatic episode, as there are no specific diagnostic tests for this condition 4
  • The diagnosis requires documentation of intense burning pain of the extremities (mainly feet, less frequently hands) 4
  • Erythema and heat of the skin during episodes are also essential for diagnosis 4
  • The presence of thrombocytosis (elevated platelet count) should be specifically sought in laboratory tests 5
  • Screening for autoimmune causes, such as lupus erythematosus, should be considered using tests like ANA and ENA 5, 6
  • Blood glucose testing should be performed to rule out diabetes 5
  • A medication review should be conducted to identify potential triggering drugs (calcium antagonists, ergot derivatives) 5, 6

Neurophysiological Tests

  • The evidence of neuropathy of small and large fibers is strongly associated with erythromelalgia 4
  • Electromyography and nerve conduction studies show anomalies in almost 50% of patients 4, 6
  • Thermoregulatory sweat testing reveals marked anomalies in about 90% of patients, representing an excellent measure of small fiber cutaneous neuropathy 4, 6
  • Quantitative sudomotor axon reflex testing is used for functional evaluation of small fibers 4

Genetic Tests

  • Genetic testing for SCN9A mutations is recommended, especially in cases with early onset (childhood or adolescence) or family aggregation 4, 6
  • About 5% of patients have a family history with identifiable SCN9A mutations 6
  • However, there are families with primary erythromelalgia without detectable SCN9A variants, suggesting other genes are involved 4

REFERENCES